Capital Insight Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,443
| Closed | -$203K | – | 171 |
|
|
2023
Q2 | $203K | Sell |
2,443
-852
| -26% | -$70.9K | 0.05% | 170 |
|
|
2023
Q1 | $251K | Sell |
3,295
-855
| -21% | -$65.2K | 0.06% | 151 |
|
|
2022
Q4 | $344K | Sell |
4,150
-2,065
| -33% | -$171K | 0.09% | 127 |
|
|
2022
Q3 | $493K | Sell |
6,215
-8,513
| -58% | -$675K | 0.13% | 110 |
|
|
2022
Q2 | $1.09M | Sell |
14,728
-1,620
| -10% | -$120K | 0.26% | 99 |
|
|
2022
Q1 | $1.47M | Sell |
16,348
-785
| -5% | -$70.5K | 0.3% | 100 |
|
|
2021
Q4 | $1.92M | Sell |
17,133
-3,052
| -15% | -$342K | 0.39% | 92 |
|
|
2021
Q3 | $2.54M | Sell |
20,185
-172
| -0.8% | -$21.6K | 0.55% | 66 |
|
|
2021
Q2 | $2.76M | Sell |
20,357
-383
| -2% | -$51.9K | 0.62% | 62 |
|
|
2021
Q1 | $2.81M | Sell |
20,740
-767
| -4% | -$104K | 0.68% | 54 |
|
|
2020
Q4 | $3.03M | Sell |
21,507
-1,140
| -5% | -$161K | 0.76% | 43 |
|
|
2020
Q3 | $2.52M | Buy |
22,647
+4,031
| +22% | +$449K | 0.71% | 51 |
|
|
2020
Q2 | $2.08M | Buy |
+18,616
| New | +$2.08M | 0.66% | 53 |
|